Airway Therapeutics, a Sharonville biotechnology company focused on developing ways to prevent and treat lung disease in premature babies, has hired Dr. Paul Kingma as chief medical officer.
Kingma is attending neonatologist at Cincinnati Children’s Hospital and associate professor of pediatrics in the University of Cincinnati’s Department of Pediatrics.
Click here to read the complete article.
Story excerpt provided by Cincinnati Business Courier.
Written by Barrett J. Brunsman.
Originally published August 27, 2018.